AGIOS PHARMACEUTICALS, INC.
AGIO
DELAYED 1 MONTH
9 insider filings · Latest: Mar 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Mar 9 8:12 PM | Krishnan ViswanadhanChief Corp Dev & Strategy | Sale | 2,959 | $27.80 | $82.3K | 5,141(D) | View → |
| Mar 3, 2026 | Mar 5 9:08 PM | Theodore James Washburn Jr.Principal Accounting Officer | Sale | 5,272 | $28.88 | $152.3K | 868(D) | View → |
| Mar 2, 2026 | Mar 3 9:17 PM | Brian GoffDirector, Chief Executive Officer | Sale | 18,055 | $28.96 | $522.9K | 164,548(D) | View → |
| Mar 2, 2026 | Mar 3 9:17 PM | James William BurnsChief Legal Officer | Sale | 5,218 | $28.96 | $151.1K | 44,086(D) | View → |
| Mar 2, 2026 | Mar 3 9:15 PM | Sarah GheuensChief Medical Officer | Sale | 4,055 | $28.96 | $117.4K | 74,406(D) | View → |
| Mar 2, 2026 | Mar 3 9:14 PM | Cecilia JonesChief Financial Officer | Sale | 5,035 | $28.96 | $145.8K | 49,328(D) | View → |
| Mar 2, 2026 | Mar 3 9:13 PM | Tsveta MilanovaChief Commercial Officer | Sale | 2,868 | $28.96 | $83.1K | 41,591(D) | View → |
| Mar 2, 2026 | Mar 3 9:12 PM | Theodore James Washburn Jr.Principal Accounting Officer | Sale | 2,223 | $28.96 | $64.4K | 6,140(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Mar 9 8:12 PM | Krishnan ViswanadhanChief Corp Dev & Strategy | Option Exercise | 8,100 | — | 16,200(D) | View → |
| Mar 2, 2026 | Mar 3 9:17 PM | Brian GoffDirector, Chief Executive Officer | Option Exercise | 39,500 | — | 26,000(D) | View → |
| Mar 1, 2026 | Mar 3 9:17 PM | Brian GoffDirector, Chief Executive Officer | Grant/Award | 222,000 | $30.23 | 174,000(D) | View → |
| Mar 2, 2026 | Mar 3 9:17 PM | James William BurnsChief Legal Officer | Option Exercise | 17,586 | — | 7,839(D) | View → |
| Mar 1, 2026 | Mar 3 9:17 PM | James William BurnsChief Legal Officer | Grant/Award | 66,000 | $30.23 | 52,000(D) | View → |
| Mar 2, 2026 | Mar 3 9:15 PM | Sarah GheuensChief Medical Officer | Option Exercise | 13,666 | — | 8,000(D) | View → |
| Mar 1, 2026 | Mar 3 9:15 PM | Sarah GheuensChief Medical Officer | Grant/Award | 88,000 | $30.23 | 52,000(D) | View → |
| Mar 2, 2026 | Mar 3 9:14 PM | Cecilia JonesChief Financial Officer | Option Exercise | 16,969 | — | 10,607(D) | View → |
| Mar 1, 2026 | Mar 3 9:14 PM | Cecilia JonesChief Financial Officer | Grant/Award | 66,000 | $30.23 | 52,000(D) | View → |
| Mar 2, 2026 | Mar 3 9:13 PM | Tsveta MilanovaChief Commercial Officer | Option Exercise | 9,666 | — | 8,000(D) | View → |
| Mar 1, 2026 | Mar 3 9:13 PM | Tsveta MilanovaChief Commercial Officer | Grant/Award | 66,000 | $30.23 | 52,000(D) | View → |
| Mar 2, 2026 | Mar 3 9:12 PM | Theodore James Washburn Jr.Principal Accounting Officer | Option Exercise | 7,495 | — | 5,390(D) | View → |
| Mar 1, 2026 | Mar 3 9:12 PM | Theodore James Washburn Jr.Principal Accounting Officer | Grant/Award | 8,452 | — | 8,452(D) | View → |
| Mar 1, 2026 | Mar 3 9:11 PM | Krishnan ViswanadhanChief Corp Dev & Strategy | Grant/Award | 66,000 | $30.23 | 52,000(D) | View → |